Skip to main content
. 2021 Jul 15;13:5699–5709. doi: 10.2147/CMAR.S286917

Table 3.

Treatment-Related Adverse Events

Adverse Event Grade 1–2 N (%) Grade 3–4 N (%)
Any 9 (75.0) 0 (0)
Pyrexia 5 (41.7) 0 (0)
Chills 5 (41.7) 0 (0)
Headache 2 (16.7) 0 (0)
Influenza-like illness 3 (25.0) 0 (0)
Fatigue 2 (16.7) 0 (0)
Peripheral edema 1 (8.3) 0 (0)
Ulceration 1 (8.3) 0 (0)
Injections site pain 4 (33.3) 0 (0)